MAM
Tata Asset Management’s moment marketing is all we need during COVID-19
MUMBAI: It is difficult to manage being cooped up for days. But by now we all know social distancing and isolation are key to stop the spread of COVID-19 virus. Keeping a low profile is a small sacrifice that we all have to perform for everyone’s safety. The challenge is to be safe and sane during a pandemic.
Isolating the most social animal on this planet was not going to be easy, and hence, to make the most of this time, Tata Asset Management’s moment marketing initiative gives purpose to those seemingly long hours during #JantaCurfew. According to Tata Asset Management, the main idea was to remind its fellow investors and users to connect with their family in these few hours of togetherness.
Tata Asset Management’s digital team curated a fun itinerary for the entire family from 7 am to 9 pm. The tasks began with exercising and having a healthy breakfast and included some family-time activities like playing a game of monopoly with the kids.
The creatives were executed by Finace. Tata Asset Management used digital and social media platforms for this initiative.
Tata Asset Management digital and marketing head MVS Murthy says, "The #JanataCurfew was for all Indians and we wanted to run a story that cut across demography and geography. And “Family – time” is the most universal idea. We helped people find purpose in their isolation. The idea was to help families all over make the most of their time together. In many ways, it must have given tremendous joy in an otherwise difficult proposition of a lockdown.”
According to Murthy, if corona calls for social distancing, the campaign brought out the idea that the joys we seek are not outside but right inside our homes. Imagine the cackle a game of monopoly would have brought when some tried to cheat in jest or how our kitchen skills would have got brushed up when the same food you would order in was made at home and one savoured it. At the end of the day we go out for our families; #JanataCurfew was the day you stayed in with your dear ones. In the overall context, the campaign told its audience that you can meaningfully isolate and make a strong chain, while breaking a very dangerous some.
He concludes, “The moment our Prime Minister announces #JanataCurfew. We planned well in advance, kept our communication stack ready, announced a 15-hour “ to-do” list on Saturday, and then on Sunday at the stroke of every hour, the focused activity was echoed across our social handles and digital assets. We would like to believe that this is amongst the best #MomentMarketing initiatives globally. Moments are not an isolated event but they gather themselves all the while to create memories. We strung up many a memory and helped sign off the day in gratitude helping audiences count their blessings in these challenging times. However, the proposed itinerary is just not restricted for one single day. We can include this in our lives while we are practicing self-isolation for the coming 21 days.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
